Chloe Douglas-Crampton
Health Technology
Profile
Chloe Douglas-Crampton worked as a Manager-Investor Relations at Trillium Therapeutics ULC from 2004 to 2009.
Former positions of Chloe Douglas-Crampton
| Companies | Position | End |
|---|---|---|
| TRILLIUM THERAPEUTICS | Public Communications Contact | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Trillium Therapeutics ULC
 Trillium Therapeutics ULC BiotechnologyHealth Technology Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. | Health Technology |
- Stock Market
- Insiders
- Chloe Douglas-Crampton
